SHARONDA WASHINGTON: Open Payments
NPI 1396427811 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,249 in 107 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $998 · 2025 $2,249
Food & beverage: $2,241Education: $7
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 22 | $511 |
| ABBVIE INC. | 20 | $406 |
| Boston Scientific Corporation | 7 | $222 |
| PFIZER INC. | 14 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $135 |
| Neurocrine BioSciences, Inc. | 5 | $134 |
| Lundbeck LLC | 5 | $110 |
| IBSA Pharma Inc. | 2 | $74 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| SCILEX PHARMACEUTICALS INC. | 3 | $61 |
Products named: PURIFIED CORTROPHIN GEL, WaveWriter Alpha Prime 16, QULIPTA, NURTEC ODT, UBRELVY, RELISTOR, INGREZZA, VYEPTI.
Industry payments across IN — which companies pay providers there.
